Research Paper Volume 16, Issue 9 pp 8110—8141
Revealing prognostic insights of programmed cell death (PCD)-associated genes in advanced non-small cell lung cancer
Figure 7. The molecular docking posture predicting for the sensitive anti-tumor drugs and targeted PCD genes. (A) Docking position of CCL14 active pocket with navitoclax. (B) Docking position of CPA3 active pocket with navitoclax. (C) Docking position of CX3CR1 with navitoclax. (D) Docking position of IKZF3 with AZD1480. (E) Docking position of KIF21B with MG-132.